The complaint describes Medtronic's actions as “immoral, unethical, oppressive and unscrupulous.”

Juan Carlos Plana Gomez, MD, discussed how cardiology and oncology programs can work together to provide high-quality patient care.

Shockwave and two other healthcare companies in the cardiovascular health space are considered attractive options for investors looking to expand their portfolios. 

Some heart teams may only target the culprit lesions when treating older patients, but new research confirms this increases the risk of several unfavorable outcomes. 

Researchers explored data from more than 2,300 patients, categorizing all bleeding events based on updated VARC-3 definitions. The team's final analysis was published in JACC: Cardiovascular Interventions.

Purvi Parwani, MD, discussed the trend toward multimodality imaging for heart failure management. All modalities have their own weaknesses, she explained. 

This represents the latest iteration of the Watchman technology, which was first approved by the FDA back in 2020. 

Once physicians confirm a patient's CAD risk is low, they can feel comfortable putting diagnostic testing on hold. 

If successful, the group's first-in-class medication would be able to target inflammation in CVD patients before it even occurs. 

Reviewing 20 years’ worth of data, researchers have found children with Down syndrome are imaged more often than others and, in the process, get exposed to significantly more ionizing radiation.

The American Society of Nuclear Cardiology is pushing payers to more consistently and correctly cover medically necessary scans without prior authorization.